Memantine and Donepezil Hydrochlorides Extended-release is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Memantine Hydrochloride; Donepezil Hydrochloride.
| Product ID | 69238-1248_397c2949-6b6e-4927-9e98-b0dfda3a5449 |
| NDC | 69238-1248 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Memantine and Donepezil Hydrochlorides Extended-release |
| Generic Name | Memantine And Donepezil |
| Dosage Form | Capsule, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-02-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA208328 |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Substance Name | MEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE |
| Active Ingredient Strength | 14 mg/1; mg/1 |
| Pharm Classes | NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |